Guide to foreign prices and formal purchase channels of Boiscetam

Brivaracetam (Brivaracetam) is a new anti-epileptic drug mainly used for the auxiliary treatment of partial seizures. Due to its good efficacy and tolerability, it has gradually gained recognition in the international market in recent years. However, Brivaracetam has not yet been officially launched in China, which makes domestic patients temporarily unable to purchase the drug directly through formal channels.

In overseas markets, the original drug of Brivaracetam has been put on the market and the common specifications are 50mg*60 tablets. According to market conditions, the price of this specification is around 4000 multiple yuan. Because the drug is an imported original version, the price is relatively high, but its efficacy and quality are guaranteed, and it is suitable for patients who have higher requirements for treatment.

For domestic patients, since it is not yet on the market in China, if they really need to use Brivaracetam, they can usually only obtain it through overseas purchasing agents or cross-border e-commerce channels. There are certain risks in this type of purchasing method, including the difficulty in fully guaranteeing the authenticity of the drug, uncertain storage conditions during transportation, and lack of after-sales service. Patients should choose formal channels carefully, and it is best to use them under the guidance of a doctor.

In the future, with the improvement of the domestic drug approval process and the relaxation of drug import policies, Brivaracetam is expected to be officially launched in the domestic market, and patients will be able to obtain the drug more conveniently and safely. At the same time, patients should pay close attention to relevant policies and hospital dynamics, and obtain the latest drug purchasing information and medication guidance in a timely manner.

Reference materials:https://www.drugs.com